PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Hypertens. Author manuscript; available in PMC 2010 August 4.
Published in final edited form as:
PMCID: PMC2915542
NIHMSID: NIHMS190003

IMPLICATION OF CHROMOSOME 13 ON HYPERTENSION AND ASSOCIATED DISORDERS IN LYON HYPERTENSIVE (LH) RATS

Abstract

Hypertension and associated disorders are major risk factors for cardiovascular disease. The Lyon Hypertensive rat (LH) is a genetically hypertensive strain that exhibits spontaneous and salt-sensitive hypertension, exaggerated proteinuria, high body weight, hyperlipidemia and elevated insulin-to-glucose ratio. Previous genetic mapping identified Quantitative Trait Loci (QTL) influencing blood pressure on chromosome 13 (RNO13) in several models of hypertension. To study the effects of a single chromosome on the mapped traits, we generated consomic strains by substituting LH RNO13 with that of the normotensive Brown Norway (BN) strain (LH-13BN) and reciprocal consomics by substituting a BN RNO13 with that of LH (BN-13LH). These reciprocal consomic strains, as well as the two parental strains were characterized for blood pressure, metabolic and morphological parameters. Compared to LH parents, LH-13BN rats showed decreased mean blood pressure (up to −24 mmHg on 2%NaCl in the drinking water), urine proteins and lipids, and increased body weight. Differences between BN-13LH and BN rats are much smaller than those observed between LH-13BN and LH rats, demonstrating the effects of the highly resistant BN genome background. Plasma renin activity is not affected by the substitution of RNO13, despite the significant blood pressure differences.

The present work demonstrates that RNO13 is a determinant of BP, proteinuria, and plasma lipids in the LH rat. The distinct phenotypic differences between the consomic LH-13BN and the LH make it a powerful model to determine genes and pathways leading to these risk factors for cardiovascular and renal disease.

Keywords: rat, consomic, hypertension

INTRODUCTION

Hypertension is an important public health problem affecting about 65 million individuals in the United States alone [1]. Essential hypertension is traditionally viewed as a consequence of interactions between environmental and genetic factors (multifactorial). Despite numerous attempts, the majority of these genetic determinants remain to be identified [2]. One way to avoid some of the complications associated with genetic research in humans (heterogeneity of population, variability of environment), is to use animals models. Because the coding regions of the rat genome sequence are on average > 85% identical to that of man, there is a clear probability that the function of some genes identified in rats can be translated directly to human or, failing this, can be used as “indicators” [3].

The Lyon Hypertensive (LH/Mav) rat strain [4], initially selected for spontaneous hypertension, shares many features with the human metabolic syndrome [5, 6, 7, 8, 9, 10, 11, 12]. Indeed, this genetically hypertensive strain also suffers salt-sensitive hypertension [13], altered renal functions with an exaggerated proteinuria [14], an excessive body weight together with increased plasma lipids and insulin-to-glucose ratio [15].

To find the genetic causes of multifactorial diseases like hypertension and associated disorders, our approach began with the identification of Quantitative Trait Loci (QTLs) which are statistically linked to the blood pressure (BP) level or to any other related phenotype. Since linkage analysis, in Dahl Salt Sensitive rats (SS) [16], Spontaneous Hypertensive Rats (SHR) [17, 18, 19, 20] as well as in LH rats [21, 22] suggested that a QTL(s) influencing blood pressure exist on rat chromosome 13 (RNO13), particularly in or near the renin gene, we sought to study the role of RNO13 in the LH rat. Therefore, we started the development of reciprocal consomic rat strains, i.e. animals which differ from the parental strains by a whole chromosome (here RNO13) using marker assisted selection [23]. We choose as normotensive control strain, the Brown Norway (BN/NHsdMcwi) rat, which is genetically divergent from the LH. LH-13BN is a LH rat in which RNO13 has been fully substituted by a BN RNO13; conversely, BN-13LH is a BN rat with a RNO13 from LH rats. Using a highly divergent strain was advantageous for two reasons: 1. it provided polymorphic markers spanning the chromosome to ensure complete chromosome substitution and 2. it allows us to uncover the maximum phenotypic differences due to genetic variation, including those not captured by the previous cross between LH and LN, strains with high genetic similarity. In order to determine the functional importance of RNO13, male LH-13BN, BN-13LH as well as the parental LH and BN strains, were characterized for not only blood pressure but also several additional phenotypes typical of LH rats, as additional significant traits could be unmasked with the substitution of the BN chromosome.

METHODS

Generation of consomic rats

The development of the consomic strains in this study involved the reciprocal transfer of the RNO13, from BN (BN/NHsdMcwi) to the genetic background of LH (LH/Mav), and from LH to the genetic background of BN. This required the production of an F1 generation by crossing a male LH with a female BN. The male F1 hybrids obtained were then mated to the desired recipient strain (LH or BN). After every backcross, DNA was extracted from tail tips and genotyped with markers evenly distributed on RNO13 at a 5 cM resolution (D13Mgh13, D13Rat39, D13Rat91, D13Mit 4, D13Mgh3, D13Rat 37, D13Rat85, D13Rat33, and D13Rat88) and 146 markers spanning the remaining genome at a ~10cM resolution as previously described [24]. Polymorphic markers were selected using the Genome Scanner Tool available at the Rat Genome Database (RGD; http://www.rgd.mcw.edu). Male rats, heterozygous for the entire chromosome, were selected for the subsequent generation of breeding. The backcrosses were followed until obtaining animals heterozygous for the full length of RNO13 and homozygous LH or BN for the rest of the genome. These animals were then intercrossed to fix the donor RNO13 as BN or LH and to obtain founders for the reciprocal consomic strains. The reciprocal consomic lines (LH-13BN and BN-13LH) were then maintained by brother-sister mating.

Animals

The animals (LH, LH-13BN, BN-13BN and BN) were housed in controlled conditions (temperature 21±1°C, humidity 60±10%, lighting 8AM to 8PM), and received a standard rat chow containing 0.3% sodium chloride (Elevage AO3, SAFE, Augy, France) and tap water ad libitum. The protocols leading to these results followed our institutional guidelines which have been approved by the veterinary services of the prefecture.

Protocol

This study is a component of a larger project to characterize consomic strains for several chromosomes derived from LH and BN rats.

Because of technical considerations, the study of all the consomic strains, as well as the parental strains, was performed simultaneously. Consequently, the parental strains were the same as in our previous study [25] and the framework of the protocol is identical for all the strains, as previously described, with the exception that some biochemical measurements differ among the different consomic strains, as described below.

Briefly, 15 weeks old male rats were equipped with telemetric radio-transmitters (TA11PAC40, Data Sciences International, St Paul, MN). After 3 weeks of recovery, BP was recorded in baseline conditions, during various salt loads (1 or 2% NaCl as drinking water) and after a washout period. 24-hours urine collections were also performed in baseline conditions, at the end of the salt load and at the end of the washout period. At the end of the study, 25 weeks-old animals fasted since 16h, were given a diazepam injection (5mg/kg, ip) and euthanized by decapitation.

Urine collection, blood and tissues sampling

A blood sample was drawn on heparin at the time of the sacrifice in fasted rats to measure creatinine, total cholesterol, triglycerides and glucose using Olympus automated tests (AU 2700 biochemistry analyzer, Olympus, Rungis, France), insulin (radioimmunoassay, DiaSorin, Antony, France) and plasma renin activity (PRA). For PRA-measurement, plasma contained additional ethylenediaminetetraacetate 20mM.

24-hours urines were used to measure creatinine, total proteins (pyrogallol red colorimetric method: AU 2700 biochemistry analyzer, Olympus, Rungis, France), sodium and potassium (flame photometer IL 943, Instrumentation Laboratory, Paris, France).

The left ventricle with septum was dissected out and weighed.

Measurement of plasma renin activity

Plasma renin activity was measured by trapping of generated angiotensin I by high affinity antibodies and subsequent radioimmunoassay [26].

Statistical analysis

Results are mean ± SEM. Statistical differences between strains were assessed using an independent t-test. LH rats were compared to BN rats and the consomic (LH-13BN and BN-13LH) were compared to their respective control (LH and BN rats).

Differences were considered statistically significant at p<0.05.

RESULTS

Body weight

Figure 1 shows, as previously described [25], that LH rats exhibit a much larger body weight than BN rats. Interestingly, LH-13BN rats showed a significantly larger body weight than LH rats, while body weight was lower in BN-13LH rats than in BN parents.

Figure 1
Time course evolution of body weight in LH (n=10), LH-13BN (n=10), BN-13LH (n=9) and BN rats (n=10). ** p<0.01 LH versus BN; †† p<0.01 LH-13BN versus LH; ‡ p<0.05, ‡‡ p<0.01 BN-13 ...

Cardiovascular parameters

Because differences in systolic, diastolic and mean BP (MBP) in the four strains are similar, only MBP values are presented here (Figure 2). Under baseline conditions, MBP of LH rats is approximately 40mmHg higher than that of BN rats (126 ± 0.9 mmHg vs 88 ± 1.6 mmHg, p<0.01). LH-13BN rats exhibited a markedly lower baseline MPB than LH rats (113 ± 1.9 mmHg vs 126 ± 0.9 mmHg, p<0.01) while BN-13LH rats showed no difference in MBP compared to BN rats (90 ± 1.6 mmHg vs 88 ± 1.6 mmHg). These MBP differences persisted throughout the study.

Figure 2
Time course of mean blood pressure (MBP) recorded by radio telemetry in LH rats (n=10), LH-13BN (n=10), BN-13LH (n=9) and BN rats (n=10). The telemetric radio-transmitters were implanted at 15 weeks of age. The blood pressure recording periods were indicated ...

As shown by Figure 3, 2% NaCl in the drinking water resulted in a more marked MBP increase in LH rats than in BN. In LH-13BN, MBP was less affected by NaCl 2% than in LH rats, although there was a 24 mmHg difference between LH and LH-13BN. BN-13LH did not differ from BN rats.

Figure 3
Percentage of mean blood pressure increase versus baseline value (R1+2) during high salt load (2% NaCl as drinking water). R6 and R7 correspond respectively to 5 and 7 days under high salt load. ** p<0.01 LH versus BN; † p<0.05 ...

The relative (mg/100g of body weight) left ventricle (LV) weight was higher in LH than in BN rats (247 ± 1mg/100g vs 199 ± 4mg/100g, p<0.01). In LH-13BN, the relative LV weight was decreased compared to LH rats (219 ± 3mg/100g vs 247 ± 1mg/100g, p<0.01) while, in BN-13LH rats, there was a non-significant increase in relative LV weight compared to BN rats (207 ± 3mg/100g vs 199 ± 4mg/100g).

Renal function and plasma renin activity (Table 1)

Table 1
Renal function and plasma renin activity in LH, LH-13BN, BN-13LH and BN rats.

The glomerular filtration rate (GFR), approximated by creatinine clearance, did not consistently differ among the four strains. However, urinary excretion of proteins was 6 to 11 fold greater in LH than in BN rats. BN-13LH exhibited the same proteinuria as the BN while, in LH-13BN rats, urinary excretion of proteins was 50% lower than that of LH parents.

Under baseline conditions, relative urinary excretion of Na+ did not consistently differ among the four strains. However, at the end of the salt load, urinary excretion of Na+ was significantly higher in LH than in BN rats. It was significantly lower in LH-13BN than in LH while it was higher in BN-13LH than in BN parents.

As shown by Table 1, before and after salt load, the Na/K ratio was lower in LH and LH-13BN than in BN and BN-13LH. At the end of the salt load, i.e. in 23 weeks old rats, these differences were less marked and the BN-13LH exhibited the higher Na/K ratio.

LH rats showed a lower plasma renin activity than BN rats (Table 1). However, LH-13BN and BN-13LH rats exhibited the same level of plasma renin activity as their parental controls.

Metabolism (Table 2)

Table 2
Plasma characteristics in fasted 25 week-old LH, LH-13BN, BN-13LH and BN rats.

Plasma total cholesterol and triglycerides were higher in fasted LH than in BN rats. Plasma total cholesterol was markedly decreased in LH-13BN rats compared to LH rats but remained higher than in BN-13LH and BN rats. LH-13BN also showed decreased plasma triglycerides compared to LH rats while BN-13LH exhibited the same level of triglycerides as BN rats.

In fasted conditions, the four strains exhibited similar glycemia; however, the insulin- to-glucose ratio was significantly elevated in both LH and LH-13BN compared to BN and BN-13LH. No significant differences were found between the consomics and their respective parental strains.

DISCUSSION

We developed consomic rats, which differ from their parents by less than 5% of their genome (RNO13), because this approach provides a well-controlled model to dissect the genetic and physiological components of complex diseases such as BP and metabolic abnormalities due to a locus or loci on a single chromosome. Using this approach in RNO13 reciprocal consomics allowed us to confirm the effects of LH chromosome 13 on blood pressure regulation and also allowed us to identify novel effects of LH RNO13 on plasma lipids, protein excretion, and body weight.

While the most likely choice for consomics might have been LH and its commonly used normotensive control LN (Lyon Normotensive), the high genetic similarity between these two strains, simultaneously selected from the same colony of outbred Sprague Dawley, and the lack of markers available at the beginning of the project greatly reduced the ability to ensure substitution of the entire chromosome. Therefore, in order to substitute RNO13 in its entirety, we sought to use a donor strain that was more genetically diverse – BN. Our results from introducing the BN RNO13, were not completely reflective of the results from the previous linkage study involving the LH and LN rat strains. This could be due to the effects of a mixed genome background in the LH × LN cross or due to the genome differences between the LN and BN strains. Likely both scenarios are playing a role. However, the use of the BN as a chromosome donor offered some distinct advantages for genetic dissection of hypertension and phenotypes related to the metabolic syndrome in the LH rat. The LH and LN strains share over 90% genetic identity, as evidenced by the genotyping of >20,000 SNPs spanning the genome [27], while LH and BN share less than 5% genome identity. Therefore, the high genetic similarity between the LH and LN means many disease susceptible alleles would remain unidentified as they are actually shared between the strains. By introgressing the BN RNO13, we recapitulated the blood pressure phenotype on RNO13 that also mapped in the genetic cross between the LH and LN. Furthermore, we were able to identify novel loci where LH confers susceptibility to dyslipidemia and related features of the metabolic syndrome. In and of itself, the consomic strain has uncovered several interesting phenotypes that have genetic effects initiated by chromosome substitution. Indeed, this could have been our starting point, rather than first performing a large mapping cross followed by consomic dissection. Because we have the ability to generate overlapping congenics strains derived from the consomics, we now are able to dissect the phenotypes and to identify those genes, which is a distinct advantage of mapping using consomics compared to genetically unique F2 offspring that cannot be further studied after the initial mapping. Moreover, the genome of the BN strain has been sequenced [28], extensively characterized [29] and used as normotensive control strain for the development of consomic strains in other model of hypertension [30, 31].

The integration of a BN RNO13 in the LH genetic background induced significant differences from the parental LH while the reciprocal consomic (the integration of a LH RNO13 in the BN background) did not always show a phenotypic difference. It is likely that additional background susceptibility factors are required which are not found in BN rat, as has been seen in other studies [32] or that the BN rat is genetically resistant to hypertension and other characteristics of the metabolic syndrome. It is also likely the BN genome is highly resistant to high blood pressure and that the introduction of a single susceptibility factor from the LH is not sufficient to overcome homeostatic pressure keeping blood pressure regulated. This is not a new concept by any means, even when generating consomics and congenics from the same strains as used in mapping crosses. For example, in one study we recently published [33], introgression of all three major BP QTL alleles from the Genetically Hypertensive (GH) rat, independently or in a triple congenic, onto the background of the BN rat was not sufficient to significantly raise blood pressure. Conversely, consomics are very useful for identifying additional loci in the absence of genome background effects. For example, in an F2 male cohort from a mapping cross between the Dahl Salt Sensitive (SS) and the normotensive BN rats [34], a blood pressure QTL was not determined on RNO13, yet the SS-13BN consomic shows a significant decrease in blood pressure and is being studied extensively for additional cardiovascular phenotypes [30, 35, 36, 37]. Importantly, the goal of our work is to identify the factors that alter the phenotypes in the LH rat. Therefore, the fact that replacing the LH RNO13 with that of a highly resistant BN, resulted a clear and significant decrease in blood pressure, allows us to generate congenic lines with clear phenotypic differences and increases our likelihood of identifying the disease-causing alleles. Given we have the reciprocal consomics available (BN-13LH), we could also pursue the mapping of BN modifier genes by an F2 intercross between BN-13LH and LH.

Measures of plasma lipids showed LH rats have higher plasma concentrations of cholesterol and triglycerides than BN rats, similar to that of LN controls [15]. The introduction of a BN RNO13 in a LH genetic background reduced triglycerides and cholesterol, while the introduction of an LH RNO13 in a BN background did not affect these parameters (again we would hypothesize BN has strong compensatory mechanisms to regulate plasma lipids). This suggests that RNO13 is involved in the spontaneous hyperlipidemia shown by LH rats. The previous linkage study failed to reveal any QTL influencing plasma lipids on this chromosome [22]; the introduction of a different donor strain or the differences in the genome background can lead to the identification of new loci influencing a trait [23, 38]. The substitution of the LH RNO13 markedly reduced plasma triglycerides. Interestingly, in our previous study [25], the replacement of LH RNO17 with that of the BN, also reduced plasma triglycerides to the level observed in BN parents suggesting a strong independent effect of RNO17 on hyperlipidemia or a common pathway with major components on both chromosomes. Taken together, these results allow us to hypothesize that the hypertriglyceridemia observed in LH rats is controlled by loci in at least two chromosomes (RNO17 and RNO13). It remains to be seen if there is epistatic relationships between these loci or if they fall within independent regulatory pathways. The generation of double consomic (LH-17BN.13BN) will help address potential interactions.

Interestingly, LH-13BN rats have a significantly increased body weight compared to LH, and BN-13LH a decreased body weight compared to BN. Such a result was unexpected. First, as the LH rats are significantly heavier than BN, we would have expected the substitution of an LH RNO13 with that of a BN would reduce body weight and, conversely, the substitution of a BN chromosome with that of LH would result in higher body weight. Furthermore, our genetic linkage studies between LH and LN rats [21, 22] failed to reveal significant body weight QTL on RNO13. Our results suggest that a gene(s) on LH RNO13 actually contributes to reduced weight, but that genes on other chromosomes (e.g. RNO1 and RNO17) play a stronger role and determine the overweight phenotype seen in the LH rat [22, 25]. In further studies, it will be important to investigate if the modification of body weight is the consequence of a change in height or in adiposity and to evaluate the repartition of this adiposity. However, what is intriguing is that the consomic strains have allowed us to clearly partition body weight from dyslipidemia as both reciprocal consomics show marked opposite effects of chromosome substitution on body weight and plasma lipid levels.

Under baseline diet conditions, mean blood pressure is decreased in LH-13BN compared to LH rats. This difference is more marked than previously observed in LH-17BN consomic rats [25]. Thus the substitution of RNO13 independently influences blood pressure in LH rats. However, the converse is not true: the introduction of a LH RNO13 in a BN background did not significantly increased BP. During salt load, BP remained stable in BN while it increased gradually in BN-13LH, LH-13BN and LH rats. This demonstrates that RNO13 is partially implicated in the salt sensitivity observed in LH rats. Similar data were reported in Dahl salt sensitive rats in which the introduction of a BN RNO13 conferred protection from salt induced hypertension [30]. Recently the generation of overlapping congenics from these consomic rats demonstrated that the RNO13 contain 4 regions that interact epistatically. Among these, two of them were sex specific [36].

Similarly, the urinary Na/K ratio, which is inversely related to mineralocorticoids activity, was lower in LH and LH-13BN compared to BN and BN-13LH. This is in accordance with the increase in mineralocorticoids found in LH rats [39]. However, the lack of significant difference due to the substitution of RNO13 suggests it is independent of RNO13.

In LH-13BN, total urinary excretion of proteins is reduced compared to LH parents. However, because the reduction in protein excretion could also be the consequence of the decrease of the deleterious effects of hypertension on the kidneys, we can not definitively conclude that this reduction is directly influenced by specific RNO13 genes. However, generation of congenic substrains should enable us to examine independent and pleiotropic gene effects.

Finally, this study allowed us to confirm that LH rats are a model of low renin hypertension [40]. Because LH-13BN and BN-13LH rats exhibit the same level of plasma renin activity as their controls (LH and BN rats, respectively) and LH and BN rats differ by a polymorphism of the intron A of the renin gene [41], it is unlikely that the level of plasma renin activity is related to this polymorphism, and may in fact be regulated by loci on another chromosome, i.e. in trans. We can also conclude that, in our model, an important part of hypertension is independent of plasma renin activity level.

Taken together these results allowed us to dissect characteristics of LH rats related to hypertension and metabolic syndrome. It is interesting to observe that several parameters such as BP, protein excretion and plasma lipids evolved similarly and independently of plasma renin activity. Although this study does not allow us to entirely exclude renin as a candidate gene for spontaneous hypertension in the LH rat, it demonstrates that, if the renin gene is a determinant of essential hypertension in our model, this occurs independently of plasma renin activity.

According to the current data in the Rat Genome Database, which is responsible for curating all rat genes, there are 826 genes on rat RNO13.To identify other potential candidate gene, we queried PubMed for genes on RNO13 annotated with the terms ‘hypertension OR blood pressure OR lipids OR metabolic syndrome’. Thirteen genes in addition to Renin were identified: Adora1 (adenosine A1 receptor); Ptgs2 (prostaglandin-endoperoxide synthase 2; aka Cox2); RGD1307782 (similar to Williams-Beuren syndrome critical region protein 27); Atp1a2 (ATPase, Na+/K+ transporting, alpha 2 polypeptide); Soat1 (sterol O-acyltransferase 1); Avpr1b (arginine vasopressin receptor 1B); Hsd11b1 (hydroxysteroid 11-beta dehydrogenase 1); LOC679692 (similar to lysophosphatidylglycerol acyltransferase 1); Selp (selectin, platelet); Myoc (myocilin); Rgs2 (regulator of G-protein signaling 2); Rgs5 (regulator of G-protein signaling 5); Prdx6 (peroxiredoxin 6). Until we have generated and characterized congenic strains derived from the consomic strains, we cannot formally include or exclude any of these, but they are candidates for follow-up in congenic and gene expression studies.

In conclusion, this work shows that the consomic strains approach is a useful step in the dissection of a highly complex disease like hypertension and components of the metabolic syndrome. However, one of the limitations of this kind of study is that loci mapped as a single QTL are more often composed of multiple QTLs with small and/or opposing effects on the trait of interest. Therefore the observed phenotype in the consomic strain is the sum of all allelic variation between the parental strains. Since we demonstrated here that RNO13 of LH rats has a significant influence on hypertension we can use these consomic animals to develop overlapping congenic strains [42] for further dissection of the factors on RNO13. The same strategy permitted Moreno et al. to identify four regions within RNO13 influencing blood pressure in SS rat with sexual dimorphisms [36]. By this approach, the study of males and females in overlapping congenics derived from our consomic lines may allow us to further understand the complex actions and interactions in regulating BP and metabolic abnormalities shown by LH rats. Interestingly, there is a very close phylogenetic relationship between the SS and the LH rats [27]. Given the fact that the same BN donor strain (BN/NHsdMcwi) was used in this study as that of the SS-13BN strain [36], future genotype-phenotype correlations could utilize these genetic similarities in assessing candidate genes or modifier gene for common traits measured in each consomic or parental lines.

ACKNOWLEDGEMENTS

We would like to thank Dr R. Cohen for insulin measurement.

This work was supported in part by NIH HL089895 (AEK). SG was funded by a “Fondation pour la Recherche Médicale” doctoral fellowship.

Abbreviations

BP
Blood Pressure
BN
Brown Norway
GFR
Glomerular Filtration Rate
GH
Genetically Hypertensive
LH
Lyon Hypertensive
LN
Lyon Normotensive
LV
Left Ventricle
MBP
Mean Blood Pressure
PRA
Plasma Renin Activity
QTL
Quantitative Trait Locus
RNO13
Rat Chromosome 13
SHR
Spontaneous Hypertensive Rat
SS
Dahl Salt Sensitive

Footnotes

Conflict of interest: the authors have no conflict of interest to declare

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

1. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69–75. [PubMed]
2. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–78. [PMC free article] [PubMed]
3. Cowley AW., Jr Genomics and homeostasis. Am J Physiol Regul Integr Comp Physiol. 2003;284:R611–27. [PubMed]
4. Dupont J, Dupont JC, Froment A, Milon H, Vincent M. Selection of three strains of rats with spontaneously different levels of blood pressure. Biomedicine. 1973;19:36–41. [PubMed]
5. Reaven GM. Insulin and hypertension. Clin Exp Hypertens A. 1990;12:803–16. [PubMed]
6. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991;14:1132–43. [PubMed]
7. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X) Diabetes. 1992;41:715–22. [PubMed]
8. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–9. [PubMed]
9. Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C, National Heart, Lung, and Blood Institute. American Heart Association Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13–8. [PubMed]
10. Fujita T. Spotlight on renin. The renin system, salt-sensitivity and metabolic syndrome. J Renin Angiotensin Aldosterone Syst. 2006;7:181–3. [PubMed]
11. Uzu T, Kimura G, Yamauchi A, Kanasaki M, Isshiki K, Araki S, et al. Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension. J Hypertens. 2006;24:1627–32. [PubMed]
12. Hoffmann IS, Cubeddu LX. Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome. J Hum Hypertens. 2007;21:438–44. [PubMed]
13. Florin M, Lo M, Liu KL, Sassard J. Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int. 2001;59:1865–72. [PubMed]
14. Vincent M, Cartier R, Privat P, Benzoni D, Samani NJ, Sassard J. Major cardiovascular risk factors in Lyon hypertensive rats. A correlation analysis in cosegregating population. J hypertens. 1996;14:469–74. [PubMed]
15. Vincent M, Boussairi EH, Cartier R, Lo M, Sassolas A, Cerutti C, et al. High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat. J Hypertens. 1993;11:1179–85. [PubMed]
16. Rapp JP, Wang SM, Dene H. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science. 1989;243:542–4. [PubMed]
17. Kurtz TW, Simonet L, Kabra PM, Wolfe S, Chan L, Hjelle BL. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest. 1990;85:1328–32. [PMC free article] [PubMed]
18. Sun L, McArdle S, Chun M, Wolff DW, Pettinger WA. Cosegregation of the renin gene with an increase in mean arterial blood pressure in the F2 rats of SHR-WKY cross. Clin Exp Hypertens. 1993;15:797–805. [PubMed]
19. Samani NJ, Gauguier D, Vincent M, Kaiser MA, Bihoreau MT, Lodwick D, et al. Analysis of quantitative trait loci for blood pressure on rat chromosomes 2 and 13. Age-related differences in effect. Hypertension. 1996;28:1118–22. [PubMed]
20. Yu H, Harrap SB, Di Nicolantonio R. Cosegregation of spontaneously hypertensive rat renin gene with elevated blood pressure in an F2 generation. J Hypertens. 1998;16:1141–7. [PubMed]
21. Dubay C, Vincent M, Samani NJ, Hilbert P, Kaiser MA, Beressi JP, et al. Genetic determinants of diastolic and pulse pressure map to different loci in Lyon hypertensive rats. Nat Genet. 1993;3:354–7. [PubMed]
22. Bilusic M, Bataillard A, Tschannen MR, Gao L, Barreto NE, Vincent M, et al. Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the lyon hypertensive rat. Hypertension. 2004;44:695–701. [PubMed]
23. Nadeau JH, Singer JB, Matin A, Lander ES. Analysing complex genetic traits with chromosome substitution strains. Nat Genet. 2000;24:221–5. [PubMed]
24. Jacob HJ, Brown DM, Bunker RK, Daly MJ, Dzau VJ, Goodman A, et al. A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet. 1995;9:63–9. [PubMed]
25. Gilibert S, Kwitek AE, Hübner N, Tschannen M, Jacob HJ, Sassard J, Bataillard AP. Effects of chromosome 17 on features of the metabolic syndrome in the Lyon hypertensive rat. Physiol Genomics. 2008;33:212–7. [PubMed]
26. Nussberger J, Aubert JF, Bouzourene K, Pellegrin M, Hayoz D, Mazzolai L. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension. 2008;51:1306–11. [PubMed]
27. STAR Consortium SNP and haplotype mapping for genetic analysis in the rat. Nat Genet. 2008;40:560–6. [PubMed]
28. Rat Genome Sequencing Project Consortium Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature. 2004;428:493–521. [PubMed]
29. Kwitek AE, Jacob HJ, Baker JE, Dwinell MR, Forster HV, Greene AS, et al. BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. Physiol genomics. 2006;25:303–13. [PubMed]
30. Cowley AW, Jr, Roman RJ, Kaldunski ML, Dumas P, Dickhout JG, Greene AS, Jacob HJ. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension. 2001;37:456–61. [PubMed]
31. Kren V, Simáková M, Musilová A, Zídek V, Pravenec M. SHR.BN-congenic strains for genetic analysis of multifactorially determined traits. Folia Biol (Praha) 2000;46:25–9. [PubMed]
32. Monti J, Plehm R, Schulz H, Ganten D, Kreutz R, Hübner N. Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10. Hum Mol Genet. 2003;12:435–9. [PubMed]
33. Bilusić M, Moreno C, Barreto NE, Tschannen MR, Harris EL, Porteous WK, et al. Genetically Hypertensive Brown Norway congenic rat strains suggest intermediate traits underlying genetic hypertension. Croat Med J. 2008;49:586–99. [PMC free article] [PubMed]
34. Stoll M, Cowley AW, Jr, Tonellato PJ, Greene AS, Kaldunski ML, Roman RJ, et al. A genomic-systems biology map for cardiovascular function. Science. 2001;294:1723–6. [PubMed]
35. Cowley AW, Jr, Roman RJ, Jacob HJ. Application of chromosomal substitution techniques in gene-function discovery. J Physiol. 2004;554:46–55. [PubMed]
36. Moreno C, Kaldunski ML, Wang T, Roman RJ, Greene AS, Lazar J, et al. Multiple blood pressure loci on rat chromosome 13 attenuate development of hypertension in the Dahl S hypertensive rat. Physiol Genomics. 2007;31:228–35. [PubMed]
37. Mattson DL, Dwinell MR, Greene AS, Kwitek AE, Roman RJ, Jacob HJ, Cowley AW., Jr Chromosome substitution reveals the genetic basis of Dahl salt-sensitive hypertension and renal disease. Am J Physiol Renal Physiol. 2008;295:F837–42. [PubMed]
38. Singer JB, Hill AE, Burrage LC, Olszens KR, Song J, Justice M, et al. Genetic dissection of complex traits with chromosome substitution strains of mice. Science. 2004;304:445–8. [PubMed]
39. Aguilar F, Lo M, Claustrat B, Saez JM, Sassard J, Li JY. Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats. Hypertension. 2004;43:87–93. [PubMed]
40. Sassard J, Lo M, Liu KL. Lyon genetically hypertensive rats: an animal model of “low renin hypertension” Acta Pharmacol Sin. 2003;24:1–6. [PubMed]
41. Rapp JP, Dene H, Deng AY. Seven renin alleles in rats and their effects on blood pressure. J Hypertens. 1994;12:349–55. [PubMed]
42. Cowley AW, Jr, Liang M, Roman RJ, Greene AS, Jacob HJ. Consomic rat model systems for physiological genomics. Acta Physiol Scand. 2004;181:585–92. [PubMed]